C07J 13/002
Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double
Official title: {with double bond in position 13 (17)}
C07J13/002 (Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double) appears on 18 US grants and 5 published applications in this corpus.
Search patents in C07J- Granted patents
- 18
- Published applications
- 5
- Assignees
- 5
- Inventors
- 13
- Latest grant
- 12 Feb 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors12 Feb 2019US 10,202,413 B2Washington University
- Estrenes for inducting hypothalamic effects5 Mar 2002US 6,352,980 B1Pherin Pharmaceuticals, Inc.
- Steroids as neurochemical stimulators of the VNO to alleviate pain18 Dec 2001US 6,331,534 B1Pherin Pharmaceuticals, Inc.
- Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions31 Oct 2000US 6,140,316 APherin Corporation
- Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia12 Sep 2000US 6,117,860 APherin Pharmaceuticals, Inc.
- Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors1 Sep 2016US 2016/0251391 A9Washington University
- Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for gaba type-a receptors17 Dec 2015US 2015/0361125 A1Washington University
- Novel fusidic acid derivatives10 May 2007US 2007/0105826 A1Leo Pharma A/S
- Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods3 Oct 2002US 2002/0143001 A1
- Novel androstanes for inducing hypothalamic effects1 Aug 2002US 2002/0103391 A1
Most cited
By later US patents
- Steroids as neurochemical stimulators of the VNO to alleviate pain11US 6,331,534 B1Pherin Pharmaceuticals, Inc. · 2001
- Steroids as neurochemical stimulators of the VNO to treat paroxistic tachycardia7US 6,117,860 APherin Pharmaceuticals, Inc. · 2000
- Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods6US 5,883,087 APherin Corporation · 1999
- Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety6US 6,057,439 APherin Corporation · 2000
- Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions5US 6,140,316 APherin Corporation · 2000